Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001193125-26-426878

Chief Executive Officer sold 47,837 shares at $49.78 ($2,381,326)

  • Chief Executive Officer acquired 100,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Kulkarni Samarth · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-10-16 Exercise or conversion : show line 1 in the form +100,000 359,736 D
2026-10-19 Sale : show line 2 in the form −47,837 $49.78 $2,381,326 311,899 D
Open-market sales · 47,837 sh · avg $49.78 · $2,381,326

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-10-16 Exercise or conversion : show line 3 in the form Restricted Stock Units −100,000 200,000 D
Loading xslF345X06/ownership.xml…